Top

Published in:

Open Access 01-03-2014 | Cardiac Magnetic Resonance (E Nagel and V Puntmann, Section Editors)

Myocardial Tissue Characterization: Histological and Pathophysiological Correlation

Authors: T. A. Treibel, S. K. White, J. C. Moon

Published in: Current Cardiovascular Imaging Reports | Issue 3/2014

Abstract

Cardiovascular magnetic resonance imaging (CMR) has become the gold standard not only for cardiac volume and function quantification, but for a key unique strength: non-invasive myocardial tissue characterization. Several different techniques, separately or in combination, can detect and quantify early and established myocardial pathological processes permitting better diagnosis, prognostication and tracking of therapy. The authors will focus on the histological and pathophysiological evidence of these imaging parameters in the characterization of edema, infarction, scar and fibrosis. In addition to laying out the strengths and weaknesses of each modality, the reader will be introduced to rapid developments in T1 and T2 mapping as well as the use of contrast-derived extracellular volume for quantification of diffuse fibrosis.

Anderson KR, Sutton MG, Lie JT. Histopathological types of cardiac fibrosis in myocardial disease. J Pathol. 1979;128(2):79–85. doi:10.1002/path.1711280205.PubMedCrossRef

Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens. 1998;16(7):1031–41.PubMedCrossRef

Weber KT, Brilla CG. Myocardial fibrosis and the renin-angiotensin-aldosterone system. J Cardiovasc Pharmacol. 1992;20 Suppl 1:S48–54.PubMedCrossRef

Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation. 1994;89(1):151–63.PubMedCrossRef

Higgins CB, Herfkens R, Lipton MJ, Sievers R, Sheldon P, Kaufman L, et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol. 1983;52(1):184–8.PubMedCrossRef

Garcia-Dorado D, Oliveras J, Gili J, Sanz E, Perez-Villa F, Barrabes J, et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res. 1993;27(8):1462–9.PubMedCrossRef

Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt Jr RF, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation. 2006;113(15):1865–70. doi:10.1161/CIRCULATIONAHA.105.576025.PubMedCrossRef

Tilak GS, Hsu LY, Hoyt Jr RF, Arai AE, Aletras AH. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol. 2008;43(1):7–15. doi:10.1097/RLI.0b013e3181558822.PubMedCrossRef

Ugander M, Bagi PS, Oki AJ, Chen B, Hsu LY, Aletras AH, et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging. 2012;5(6):596–603. doi:10.1016/j.jcmg.2012.01.016.PubMedCentralPubMedCrossRef

10.

Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004;109(20):2411–6. doi:10.1161/01.CIR.0000127428.10985.C6.PubMedCrossRef

11.

Berry C, Kellman P, Mancini C, Chen MY, Bandettini WP, Lowrey T, et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging. 2010;3(5):527–35. doi:10.1161/CIRCIMAGING.109.900761.PubMedCentralPubMedCrossRef

12.

Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51(16):1581–7. doi:10.1016/j.jacc.2008.01.019.PubMedCrossRef

13.

Carlsson M, Ubachs JF, Hedstrom E, Heiberg E, Jovinge S, Arheden H. Myocardium at risk after acute infarction in humans on cardiac magnetic resonance: quantitative assessment during follow-up and validation with single-photon emission computed tomography. JACC Cardiovasc Imaging. 2009;2(5):569–76. doi:10.1016/j.jcmg.2008.11.018.PubMedCrossRef

14.

Dall'Armellina E, Karia N, Lindsay AC, Karamitsos TD, Ferreira V, Robson MD, et al. Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging. 2011;4(3):228–36. doi:10.1161/CIRCIMAGING.111.963421.PubMedCentralPubMedCrossRef

15.

Nair V, Butany J. Heart transplant biopsies: interpretation and significance. J Clin Pathol. 2010;63(1):12–20. doi:10.1136/jcp.2009.072462.PubMedCrossRef

16.

Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation. 1996;94(12):3318–26.PubMedCrossRef

17.

Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology. 2001;218(3):703–10.PubMedCrossRef

18.

Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson. 2003;5(3):505–14.PubMedCrossRef

19.••

Schelbert EB, Hsu LY, Anderson SA, Mohanty BD, Karim SM, Kellman P, et al. Late gadolinium-enhancement cardiac magnetic resonance identifies postinfarction myocardial fibrosis and the border zone at the near cellular level in ex vivo rat heart. Circ Cardiovasc Imaging. 2010;3(6):743–52. doi:10.1161/CIRCIMAGING.108.835793. The authors have taken histological validation of LGE close to a cellular level, performing extremely high-resolution ex-vivo LGE imaging on rats at 7 Tesla and compared with histological sections showing a remarkable correlation.PubMedCentralPubMedCrossRef

20.

Flett AS, Hasleton J, Cook C, Hausenloy D, Quarta G, Ariti C, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011;4(2):150–6. doi:10.1016/j.jcmg.2010.11.015.PubMedCrossRef

21.

Goldman MR, Brady TJ, Pykett IL, Burt CT, Buonanno FS, Kistler JP, et al. Quantification of experimental myocardial infarction using nuclear magnetic resonance imaging and paramagnetic ion contrast enhancement in excised canine hearts. Circulation. 1982;66(5):1012–6.PubMedCrossRef

22.

Wesbey GE, Higgins CB, McNamara MT, Engelstad BL, Lipton MJ, Sievers R, et al. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. Radiology. 1984;153(1):165–9.PubMed

23.

Wesbey G, Higgins CB, Lanzer P, Botvinick E, Lipton MJ. Imaging and characterization of acute myocardial infarction in vivo by gated nuclear magnetic resonance. Circulation. 1984;69(1):125–30.PubMedCrossRef

24.

Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218(1):215–23.PubMedCrossRef

25.

Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100(19):1992–2002.PubMedCrossRef

26.

Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation. 2002;105(2):224–9.PubMedCrossRef

27.

Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol. 2000;36(6):1985–91.PubMedCrossRef

28.

Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445–53. doi:10.1056/NEJM200011163432003.PubMedCrossRef

29.

Selvanayagam JB, Kardos A, Francis JM, Wiesmann F, Petersen SE, Taggart DP, et al. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation. 2004;110(12):1535–41. doi:10.1161/01.CIR.0000142045.22628.74.PubMedCrossRef

30.

Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104(10):1101–7.PubMedCrossRef

31.

Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation. 2006;114(1):32–9. doi:10.1161/CIRCULATIONAHA.106.613414.PubMedCrossRef

32.

Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113(23):2733–43. doi:10.1161/CIRCULATIONAHA.105.570648.PubMedCrossRef

33.

Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart. 2008;94(6):730–6. doi:10.1136/hrt.2007.122622.PubMedCrossRef

34.

Klein C, Nekolla SG, Balbach T, Schnackenburg B, Nagel E, Fleck E, et al. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging. 2004;20(4):588–93. doi:10.1002/jmri.20164.PubMedCrossRef

35.

Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361(9355):374–9. doi:10.1016/s0140-6736(03)12389-6.PubMedCrossRef

36.

Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation. 2002;106(18):2322–7.PubMedCrossRef

37.

Kim RJ, Albert TS, Wible JH, Elliott MD, Allen JC, Lee JC, et al. Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation. 2008;117(5):629–37. doi:10.1161/CIRCULATIONAHA.107.723262.PubMedCrossRef

38.

Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002;40(12):2156–64.PubMedCrossRef

39.

Wagner A, Schulz-Menger J, Dietz R, Friedrich MG. Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging. Magma. 2003;16(1):17–20. doi:10.1007/s10334-003-0007-7.PubMedCrossRef

40.

Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G, et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol. 2011;58(12):1271–9. doi:10.1016/j.jacc.2011.03.064.PubMedCrossRef

41.

Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson. 2008;10:54. doi:10.1186/1532-429X-10-54.PubMedCrossRef

42.

Zemrak F, Petersen SE. Late gadolinium enhancement CMR predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. Prog Cardiovasc Dis. 2011;54(3):215–29. doi:10.1016/j.pcad.2011.07.003.PubMedCrossRef

43.

Ismail TF, Prasad SK, Pennell DJ. Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy. Heart. 2012;98(6):438–42. doi:10.1136/heartjnl-2011-300814.PubMedCrossRef

44.

Becker AE, Heijmans CD, Essed CE. Chronic non-ischaemic congestive heart disease and endomyocardial biopsies. Worth the extra? Eur Heart J. 1991;12(2):218–23.PubMed

45.

Kehr E, Sono M, Chugh SS, Jerosch-Herold M. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging. 2008;24(1):61–8. doi:10.1007/s10554-007-9223-y.PubMedCrossRef

46.••

Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation. 2010;122(2):138–44. doi:10.1161/CIRCULATIONAHA.109.930636. The authors developed an extracellular volume technique and validated it against histology in patients with severe aortic stenosis and hypertrophic cardiomyopathy.PubMedCrossRef

47.

White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging. 2013. doi:10.1016/j.jcmg.2013.01.011.

48.

Miller CA, Naish JH, Bishop P, Coutts G, Clark D, Zhao S, et al. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume. Circ Cardiovasc Imaging. 2013;6(3):373–83. doi:10.1161/CIRCIMAGING.112.000192.PubMedCrossRef

49.

Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol. 2008;52(19):1574–80. doi:10.1016/j.jacc.2008.06.049.PubMedCrossRef

50.

Coelho-Filho OR, Shah RV, Mitchell R, Neilan TG, Moreno Jr H, Simonson B, et al. Quantification of cardiomyocyte hypertrophy by cardiac magnetic resonance: implications for early cardiac remodeling. Circulation. 2013;128(11):1225–33. doi:10.1161/CIRCULATIONAHA.112.000438.PubMed

51.••

Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH, et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J. 2012;33(10):1268–78. doi:10.1093/eurheartj/ehr481. The authors show that ECV imaging can quantitatively characterize MI, atypical diffuse fibrosis, and subtle myocardial abnormalities not clinically apparent on LGE images.PubMedCrossRef

52.••

Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation. 2012;126(10):1206–16. doi:10.1161/CIRCULATIONAHA.111.089409. In this large cohort study, the authors show in unselected patients that ECV predicts outcomes at least as strongly as left ventricular ejection fraction.PubMedCentralPubMedCrossRef

53.

Wong TC, Piehler KM, Kang IA, Kadakkal A, Kellman P, Schwartzman DS, et al. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission. Eur Heart J. 2013. doi:10.1093/eurheartj/eht193.

54.•

Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S, et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson. 2010;12:69. doi:10.1186/1532-429X-12-69. A seminal papers for the three main T1 mapping sequences.PubMedCrossRef

55.•

Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med. 2004;52(1):141–6. doi:10.1002/mrm.20110. A seminal paper for the three main T1 mapping sequences.

56.•

Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB. Saturation recovery single-shot acquisition (SASHA) for myocardial T mapping. Magn Reson Med. 2013. doi:10.1002/mrm.24878. A seminal paper for the three main T1 mapping sequences.

57.••

Kellman P, Wilson JR, Xue H, Ugander M, Arai AE. Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method. J Cardiovasc Magn Reson. 2012;14:63. doi:10.1186/1532-429X-14-63. In this work, the authors developed and evaluated a fully automated, motion-corrected and co-registered method for producing ECV maps feasible for clinical work flow.PubMedCrossRef

58.

Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart. 2012;98(19):1436–41. doi:10.1136/heartjnl-2012-302346.PubMedCrossRef

59.

Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, et al. Noncontrast t1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging. 2013;6(4):488–97. doi:10.1016/j.jcmg.2012.11.013.PubMedCrossRef

60.

Sado DM, White SK, Piechnik SK, Banypersad SM, Treibel T, Captur G, et al. The identification and assessment of anderson fabry disease by cardiovascular magnetic resonance non-contrast myocardial T1 mapping. Circ Cardiovasc Imaging. 2013. doi:10.1161/CIRCIMAGING.112.000070.

61.

Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Heart. 2013;99(13):932–7. doi:10.1136/heartjnl-2012-303052.PubMedCentralPubMedCrossRef

62.

Puntmann VO, Voigt T, Chen Z, Mayr M, Karim R, Rhode K, et al. Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy. JACC Cardiovasc Imaging. 2013;6(4):475–84. doi:10.1016/j.jcmg.2012.08.019.PubMedCrossRef

63.

Ferreira VM, Piechnik SK, Dall'armellina E, Karamitsos TD, Francis JM, Ntusi N, et al. T mapping for the diagnosis of acute myocarditis using CMR: comparison to T-weighted and late gadolinium enhanced imaging. JACC Cardiovasc Imaging. 2013. doi:10.1016/j.jcmg.2013.03.008.

64.••

Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15(1):92. doi:10.1186/1532-429X-15-92. This document provides recommendations for clinical and research T1 and ECV measurement, addressing site preparation, scan type, scan planning and acquisition, quality control, visualisation and analysis, technical development, as well as discussing controversies in the field.PubMedCrossRef

65.

Robson MD, Piechnik SK, Tunnicliffe EM, Neubauer S. T measurements in the human myocardium: the effects of magnetization transfer on the SASHA and MOLLI sequences. Magn Reson Med. 2013. doi:10.1002/mrm.24867.

66.

Coelho-Filho OR, Mongeon FP, Mitchell R, Moreno Jr H, Nadruz Jr W, Kwong R, et al. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive heart disease. Circ Cardiovasc Imaging. 2013;6(1):134–41. doi:10.1161/CIRCIMAGING.112.979815.PubMedCentralPubMedCrossRef

67.

de Jong S, Zwanenburg JJ, Visser F, der Nagel R, van Rijen HV, Vos MA, et al. Direct detection of myocardial fibrosis by MRI. J Mol Cell Cardiol. 2011;51(6):974–9. doi:10.1016/j.yjmcc.2011.08.024.PubMedCrossRef

68.

Ugander MC, Chen MY, Chen B, Bagi PS, Hsu LY, Kellman P, Arai AE. Contrast Enhanced CT and MRI Measures of Extracellular Volume Fraction Confirm Presence of Peri-Infarct Edema in Acute Myocardial Infarction (Abstract). American Heart Association 2011.

69.

Bandula S, White SK, Flett AS, Lawrence D, Pugliese F, Ashworth MT, et al. Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings. Radiology. 2013. doi:10.1148/radiol.13130130.

70.

Nacif MS, Kawel N, Lee JJ, Chen X, Yao J, Zavodni A, et al. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. Radiology. 2012;264(3):876–83. doi:10.1148/radiol.12112458.PubMedCrossRef

71.

Butler J, Fonarow GC, Gheorghiade M. Strategies and opportunities for drug development in heart failure. Jama. 2013;309(15):1593–4. doi:10.1001/jama.2013.1063.PubMedCrossRef

Title: Myocardial Tissue Characterization: Histological and Pathophysiological Correlation
Authors: T. A. Treibel
S. K. White
J. C. Moon
Publication date: 01-03-2014
Publisher: Springer US
Published in: Current Cardiovascular Imaging Reports / Issue 3/2014
Print ISSN: 1941-9066
Electronic ISSN: 1941-9074
DOI: https://doi.org/10.1007/s12410-013-9254-9

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Myocardial Tissue Characterization: Histological and Pathophysiological Correlation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Myocardial Perfusion Imaging for Risk Stratification in Asymptomatic Individuals Without Known Cardiovascular Disease

Cardiac Radionuclide Imaging After Coronary Artery Revascularization

Nuclear Cardiology in Heart Failure

Review of T1 Mapping Methods: Comparative Effectiveness Including Reproducibility Issues

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page